In the context of our findings and the pilot studies in humans demonstrating that TRE is an effective and simple dietary intervention to improve insulin sensitivity44,58, we suggest TRE as potential strategy for reducing hyperinsulinemia and thus tumor growth in cancer patients. The gene discussed is INS; the disease is Hyperinsulinemia.